Korro Bio, Inc. (KRRO)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 11
in 62 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Korro Bio, Inc.
Korro Bio, Inc. is a NASDAQ-listed Biotechnology company in the healthcare field that develops genetic therapeutics through RNA editing technology. The company is an early-stage biotech business rather than a commercial drug manufacturer, and its programs are aimed at both uncommon diseases and more widespread disorders.
Today's Snapshot
So far today, KRRO is trading flat at 12.93, in line with a flat sector.
Trading Volume
Below 10d avg (82.5K)
69.1K
vs S&P 500 Today
Outperforming Market
+0.56%
Updated: September 10, 2026 at 16:42 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$12.60 - $15.44Buy
- RSI (14)52.57Neutral
- Stochastic %K (14, 3, 3)66.78Neutral
- MACD Level (12, 26)0.05Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.